Fingerprint
Dive into the research topics of 'Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome∗'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome∗
Lindsay Rein, Karel Calero, Ronak Shah, Charles Ojielo, Kristin M. Hudock, Saba Lodhi, Farid Sadaka, Shashi Bellam, Christopher Palma, David N. Hager, Jeannie Daniel, Richard Schaub, Kevin O'hayer, Nicole M. Theodoropoulos
Research output: Contribution to journal › Article › peer-review